ENDORET GEL Trademark

Trademark Overview

On Friday, July 21, 2017, a trademark application was filed for ENDORET GEL with the United States Patent and Trademark Office. The USPTO has given the ENDORET GEL trademark a serial number of 79219799. The federal status of this trademark filing is REGISTERED as of Tuesday, May 1, 2018. This trademark is owned by BIOTECHNOLOGY INSTITUTE, S.L.. The ENDORET GEL trademark is filed in the Pharmaceutical Products category with the following description:

Biomaterial obtained from blood and consisting exclusively of human plasma, intended for tissue regeneration and for medical, therapeutic and/or esthetic purposes; blood plasma rich in growth factors
endoret gel

General Information

Serial Number79219799
Word MarkENDORET GEL
Filing DateFriday, July 21, 2017
Status700 - REGISTERED
Status DateTuesday, May 1, 2018
Registration Number5456004
Registration DateTuesday, May 1, 2018
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 13, 2018

Trademark Statements

Goods and ServicesBiomaterial obtained from blood and consisting exclusively of human plasma, intended for tissue regeneration and for medical, therapeutic and/or esthetic purposes; blood plasma rich in growth factors
Disclaimer with Predetermined Text"GEL"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, November 3, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBIOTECHNOLOGY INSTITUTE, S.L.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressES
Party NameBIOTECHNOLOGY INSTITUTE, S.L.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressES
Party NameBIOTECHNOLOGY INSTITUTE, S.L.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressES

Trademark Events

Event DateEvent Description
Friday, January 19, 2024NEW REPRESENTATIVE AT IB RECEIVED
Monday, May 1, 2023COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Monday, October 21, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, October 21, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, October 4, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, October 4, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, September 7, 2018FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, August 13, 2018FINAL DISPOSITION NOTICE SENT TO IB
Monday, August 13, 2018FINAL DISPOSITION PROCESSED
Wednesday, August 1, 2018FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, May 1, 2018REGISTERED-PRINCIPAL REGISTER
Tuesday, February 13, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 13, 2018PUBLISHED FOR OPPOSITION
Wednesday, January 24, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 2, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 13, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, December 12, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 12, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, December 9, 2017REFUSAL PROCESSED BY IB
Friday, November 17, 2017NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, November 17, 2017REFUSAL PROCESSED BY MPU
Tuesday, November 7, 2017NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, November 7, 2017APPLICATION FILING RECEIPT MAILED
Monday, November 6, 2017NON-FINAL ACTION WRITTEN
Friday, November 3, 2017ASSIGNED TO EXAMINER
Friday, November 3, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 2, 2017SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

endoret plasma blood therapeutic medical esthetic rich factors growth regeneration purposes